[Pharmacological treatment of sexual dysfunction in women].
Hilmand
Christine Bjerre
CB
Klinisk farmakologisk afdeling 7642, H:S Rigshospitalet, Blegdamsvej 9, DK-2100 København ø.
Gregersen
Nina
N
Giraldi
Annamaria G Elena
AG
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000527:Alprostadil / Q000009:adverse effects / Q000627:therapeutic use; D001058:Apomorphine / Q000009:adverse effects / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010646:Phentolamine / Q000009:adverse effects / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D018491:Dopamine Agonists; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D000527:Alprostadil; D001058:Apomorphine; D010646:Phentolamine